Study of the Effects of Chemotherapy on Memory and Other Mental Functions in Women With Breast Cancer
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00260975 |
Recruitment Status :
Completed
First Posted : December 2, 2005
Last Update Posted : September 25, 2017
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Breast Cancer |
Study Type : | Observational |
Actual Enrollment : | 112 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | A Prospective, Longitudinal Investigation of the Neuropsychological and Psychosocial Effects of Cancer Therapy |
Study Start Date : | June 2001 |
Actual Primary Completion Date : | February 2008 |
Actual Study Completion Date : | February 2008 |

Group/Cohort |
---|
Chemotherapy patients
Breast cancer patients treated with adjuvant chemotherapy of various types.
|
Hormonal patients
Breast cancer patients treated with adjuvant hormonal therapy but not chemotherapy.
|

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 50 Years to 65 Years (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- stage I or II breast cancer; woman; 50-65 years old; post-menopausal
Exclusion Criteria:
- history of previous cancer or chemotherapy; significant neurological or psychiatric history

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00260975
Principal Investigator: | Barbara Collins | OHRI |
Responsible Party: | Ottawa Hospital Research Institute |
ClinicalTrials.gov Identifier: | NCT00260975 |
Other Study ID Numbers: |
1999232-01H |
First Posted: | December 2, 2005 Key Record Dates |
Last Update Posted: | September 25, 2017 |
Last Verified: | September 2017 |
breast cancer chemotherapy hormonal therapy cognitive function chemo fog |
Breast Neoplasms Neoplasms by Site Neoplasms Breast Diseases Skin Diseases |